Previous Article | Next Article ![]()
Mol Cell Biol, April 1998, p. 2184-2195, Vol. 18, No. 4
Life Sciences Division, Berkeley National Laboratory,
Berkeley, California 947201;
Voltastrasse 39, 8044 Zürich,
Switzerland2;
Laboratory of Receptor
Biology and Gene Expression, National Cancer Institute, National
Institutes of Health, Bethesda, Maryland
208923;
Searle Research
Division/Monsanto Company, Chesterfield, Missouri
630174; and
Institute for
Veterinarian Biochemistry, University of Zürich (Irchel), 8057 Zürich, Switzerland5
Received 3 April 1997/Returned for modification 27 April
1997/Accepted 16 December 1997
We have previously described a 160-bp enhancer (BCE-1) in the
bovine
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Characterization of BCE-1, a Transcriptional Enhancer
Regulated by Prolactin and Extracellular Matrix and Modulated by
the State of Histone Acetylation
-casein gene that is activated in the presence of prolactin and extracellular matrix (ECM). Here we report the characterization of
the enhancer by deletion and site-directed mutagenesis, electrophoretic mobility shift analysis, and in vivo footprinting. Two essential regions were identified by analysis of mutant constructions: one binds
C/EBP-
and the other binds MGF/STAT5 and an as-yet-unidentified binding protein. However, no qualitative or quantitative differences in
the binding of these proteins were observed in electrophoretic mobility
shift analysis using nuclear extracts derived from cells cultured in
the presence or absence of ECM with or without prolactin, indicating
that prolactin- and ECM-induced transcription was not dependent on the
availability of these factors in the functional cell lines employed. An
in vivo footprinting analysis of the factors bound to nuclear chromatin
in the presence or absence of ECM and/or prolactin found no differences
in the binding of C/EBP-
but did not provide definitive results for
the other factors. Neither ECM nor prolactin activated BCE-1 in
transient transfections, suggesting that the chromosomal structure of
the integrated template may be required for ECM-induced transcription.
Further evidence is that treatment of cells with inhibitors of histone
deacetylase was sufficient to induce transcription of integrated BCE-1
in the absence of ECM. Together, these results suggest that the ECM induces a complex interaction between the enhancer-bound transcription factors, the basal transcriptional machinery, and a chromosomally integrated template responsive to the acetylation state of the histones.
*
Corresponding author. Berkeley National Laboratory,
Life Sciences Division, 1 Cyclotron Rd., Bldg. 83-101, Berkeley, CA
94720. Phone: (510) 486-4365. Fax: (510) 486-5586. E-mail:
mjbissell{at}lbl.gov.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|